Interleukin‐39 is a Prognostic Biomarker and Therapy Target for Sepsis
Feng‐zhi Zhang, Hai‐jun Liu, Yan Yue, Jun‐jie Gao, Jin Zhang, Wen‐wu Zhang, Yun‐long Zhang, Wei‐hua Lu, Sheng‐wei Jin, Pu‐hong Zhang · 2026
Read Interleukin‐39 is a Prognostic Biomarker and Therapy Target for Sepsis by Feng‐zhi Zhang, Hai‐jun Liu, Yan Yue, Jun‐jie Gao, Jin Zhang, Wen‐wu Zhang, Yun‐long Zhang, Wei‐hua Lu, Sheng‐wei Jin, Pu‐hong Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13562788.txt.
Description
Feng-zhi Zhang and co-authors finger interleukin-39 as both warning flag and driver in sepsis in a 2026 study. The cytokine ran high in septic patients blood at admission across two cohorts, and its level foretold who would survive the month. Single-cell reads traced the source to macrophages.
Adding the cytokine to septic mice worsened organ damage, while deleting it from macrophages protected them. It acts through a shared receptor chain that fires an inflammatory pathway. Blocking that chain in macrophages erased the harm. A drug target and a triage marker arrive in one molecule.
Catalog record
| CREATOR | Feng‐zhi Zhang, Hai‐jun Liu, Yan Yue, Jun‐jie Gao, Jin Zhang, Wen‐wu Zhang, Yun‐long Zhang, Wei‐hua Lu, Sheng‐wei Jin, Pu‐hong Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |